This program studied CSA-131, a synthetic compound that mimics natural compounds in the body that help fight bacterial and fungal infections. CSA-131 was studied for the potential to inhibit the growth of bacteria and fungi by breaking down their biofilms -- protective layers that bacteria and fungi form that make them more difficult to kill with anti-infectives -- and ultimately killing these organisms.

Status

No further development in CF is planned at this time.

Sponsor

This program was sponsored by Kinnear Pharmaceuticals and partially funded by the Cystic Fibrosis Foundation.